Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study.
Wei LiuPatrick J AntonelliPhilipp DahmTobias GerhardJoseph A C DelaneyRichard SegalStephen CrystalAlmut G WintersteinPublished in: Pharmacoepidemiology and drug safety (2018)
Use of PDE5 inhibitors is associated with a small but significantly increased risk of sudden SNHL.
Keyphrases